Activation of ClC-3 chloride channel by 17β-estradiol relies on the estrogen receptor α expression in breast cancer

2017 ◽  
Vol 233 (2) ◽  
pp. 1071-1081 ◽  
Author(s):  
Haifeng Yang ◽  
Lianshun Ma ◽  
Yawei Wang ◽  
Wanhong Zuo ◽  
Bingxue Li ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Chloride Channel ◽  
Estrogen Receptor Α ◽  
17Β Estradiol

scholarly journals PARP7 and Mono-ADP-Ribosylation Negatively Regulate Estrogen Receptor α Signaling in Human Breast Cancer Cells

Cells ◽  
2021 ◽  
Vol 10 (3) ◽  
pp. 623
Author(s):  
Marit Rasmussen ◽  
Susanna Tan ◽  
Venkata S. Somisetty ◽  
David Hutin ◽  
Ninni Elise Olafsen ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Protein Modification ◽  
Target Genes ◽  
Estrogen Receptor Α ◽  
Transactivation Domain ◽  
Adp Ribosylation ◽  
Protein Levels ◽  
17Β Estradiol ◽  
Mcf 7

ADP-ribosylation is a post-translational protein modification catalyzed by a family of proteins known as poly-ADP-ribose polymerases. PARP7 (TIPARP; ARTD14) is a mono-ADP-ribosyltransferase involved in several cellular processes, including responses to hypoxia, innate immunity and regulation of nuclear receptors. Since previous studies suggested that PARP7 was regulated by 17β-estradiol, we investigated whether PARP7 regulates estrogen receptor α signaling. We confirmed the 17β-estradiol-dependent increases of PARP7 mRNA and protein levels in MCF-7 cells, and observed recruitment of estrogen receptor α to the promoter of PARP7. Overexpression of PARP7 decreased ligand-dependent estrogen receptor α signaling, while treatment of PARP7 knockout MCF-7 cells with 17β-estradiol resulted in increased expression of and recruitment to estrogen receptor α target genes, in addition to increased proliferation. Co-immunoprecipitation assays revealed that PARP7 mono-ADP-ribosylated estrogen receptor α, and mass spectrometry mapped the modified peptides to the receptor’s ligand-independent transactivation domain. Co-immunoprecipitation with truncated estrogen receptor α variants identified that the hinge region of the receptor is required for PARP7-dependent mono-ADP-ribosylation. These results imply that PARP7-mediated mono-ADP-ribosylation may play an important role in estrogen receptor positive breast cancer.

Neuroglobin overexpression induced by the 17β-Estradiol-Estrogen receptor-α Pathway reduces the sensitivity of MCF-7 Breast cancer cell to paclitaxel

IUBMB Life ◽  
2016 ◽  
Vol 68 (8) ◽  
pp. 645-651 ◽  
Author(s):  
Marco Fiocchetti ◽  
Manuela Cipolletti ◽  
Stefano Leone ◽  
Paolo Ascenzi ◽  
Maria Marino
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Cancer Cell ◽  
Breast Cancer Cell ◽  
Estrogen Receptor Α ◽  
17Β Estradiol ◽  
Mcf 7

Potentiation of paclitaxel effect by resveratrol in human breast cancer cells by counteracting the 17β-estradiol/estrogen receptor α/neuroglobin pathway

2018 ◽  
Vol 234 (4) ◽  
pp. 3147-3157 ◽  
Author(s):  
Manuela Cipolletti ◽  
Emiliano Montalesi ◽  
Maria Teresa Nuzzo ◽  
Marco Fiocchetti ◽  
Paolo Ascenzi ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Cancer Cells ◽  
Human Breast Cancer ◽  
Breast Cancer Cells ◽  
Estrogen Receptor Α ◽  
Human Breast Cancer Cells ◽  
Human Breast ◽  
17Β Estradiol

scholarly journals Up-regulation of Pi3k/Akt Signaling by 17β-estradiol through Activation Of Estrogen Receptor-α in Breast Cancer Cells

2006 ◽  
Vol 9 (2) ◽  
pp. 91 ◽  
Author(s):  
Min Cheul So ◽  
Hong Pil Hwang ◽  
Chang Ho Lee ◽  
Hyun Jo Youn ◽  
Sung Hoo Jung ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Cancer Cells ◽  
Breast Cancer Cells ◽  
Estrogen Receptor Α ◽  
Akt Signaling ◽  
17Β Estradiol
Sign in / Sign up

Export Citation Format

Share Document